Your fact-checks will appear here
Female given name
Interim U.S. estimates for the 2024–25 influenza season show vaccination reduced medically attended flu and hospitalizations across age groups, with CDC reporting that vaccination was effective in chi...
Older adults (65+) are urged to get updated COVID-19 vaccines because they remain most at risk for severe outcomes; vaccine effectiveness against hospitalization in immunocompetent adults ≥65 was abou...
CDC reporting and analyses show COVID-19 vaccines reduce risk of severe outcomes — including hospitalization and death — with the most robust measured vaccine effectiveness (VE) against hospitalizatio...
The 2024–2025 seasonal influenza vaccines provided moderate protection against hospitalization during H3N2‑dominant periods, with interim estimates clustered in the roughly 35%–55% range depending on ...
The Centers for Disease Control and Prevention (CDC) does not publish a fixed calendar date for U.S.-specific influenza vaccine effectiveness (VE) estimates for a given season; instead, CDC’s four U.S...
Cleveland Clinic reports that it tracks vaccine safety through clinical-trial safety monitoring and routine clinical care guidance on its public pages; its patient-facing COVID vaccine guidance notes ...
Current COVID-19 vaccines targeted at recent Omicron sublineages provide , with point estimates varying by study and population: recent U.S. surveillance found roughly , while regional studies report ...